
Eisai Co., Ltd. – OTC:ESALY
Eisai Co., Ltd. stock price today
Eisai Co., Ltd. stock price monthly change
Eisai Co., Ltd. stock price quarterly change
Eisai Co., Ltd. key metrics
Market Cap | 17.63B |
Enterprise value | 2.31T |
P/E | 90.07 |
EV/Sales | 3.14 |
EV/EBITDA | 61.86 |
Price/Sales | 3.30 |
Price/Book | 3.14 |
PEG ratio | N/A |
EPS | 158.29 |
Revenue | 756.22B |
EBITDA | 96.78B |
Income | 45.36B |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 3.67% |
Oper. margin | -0.21% |
Gross margin | 74.22% |
EBIT margin | -0.21% |
EBITDA margin | 12.8% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEisai Co., Ltd. stock price history
Eisai Co., Ltd. stock forecast
Eisai Co., Ltd. financial statements
Jun 2021 | 198.89B | 42.16B | 21.2% |
---|---|---|---|
Sep 2021 | 163.45B | 4.02B | 2.46% |
Dec 2021 | 202.97B | 13.04B | 6.43% |
Mar 2022 | 190.90B | -13.87B | -7.27% |
Paying a dividend greater than earnings.
Payout ratio | 169.63% |
---|
2018 | 2.49% |
---|---|
2019 | 2.38% |
2020 | 2.63% |
2021 | 2.55% |
2022 | 2.83% |
Mar 2022 | 1239315000000 | 467.78B | 37.75% |
---|---|---|---|
Jun 2022 | 1272871000000 | 444.52B | 34.92% |
Sep 2022 | 1238702000000 | 410.57B | 33.15% |
Dec 2022 | 1251069000000 | 453.99B | 36.29% |
Jun 2021 | -14.27B | 124M | -22.53B |
---|---|---|---|
Sep 2021 | 82.68B | -8.07B | -5.41B |
Dec 2021 | 4.76B | -10.70B | -25.49B |
Mar 2022 | 44.41B | -10.18B | 4.47B |
Eisai Co., Ltd. alternative data
Aug 2023 | 11,092 |
---|---|
Sep 2023 | 11,092 |
Oct 2023 | 11,092 |
Nov 2023 | 11,092 |
Dec 2023 | 11,092 |
Jan 2024 | 11,092 |
Feb 2024 | 11,092 |
Mar 2024 | 11,092 |
Apr 2024 | 11,092 |
May 2024 | 11,092 |
Jun 2024 | 11,092 |
Jul 2024 | 11,092 |
Eisai Co., Ltd. other data
Quarter | Transcript |
---|---|
Q2 2023 7 Nov 2022 | Q2 2023 Earnings Call Transcript |
Q1 2023 6 Aug 2022 | Q1 2023 Earnings Call Transcript |
Catalyst Pharmaceuticals: Cheap For A Reason
Anavex: Drug Treatments For Early Alzheimer's Disease
Eisai And Biogen's Lecanemab: A Flawed Treatment For Alzheimer's Disease
Anavex Life Sciences: The Little Company That Did
BioVie: Treating Alzheimer's, Parkinson's, And Potentially Reversing The Biological Clock
Johnson & Johnson: Alzheimer's Disease Pipeline Could Dominate
Trading Ideas On The Upcoming CTAD 2022 Conference
Biogen: Second Time's A Charm
Biogen: Super-Strong Momentum In A Defensive Sector
-
What's the price of Eisai Co., Ltd. stock today?
One share of Eisai Co., Ltd. stock can currently be purchased for approximately $61.51.
-
When is Eisai Co., Ltd.'s next earnings date?
Unfortunately, Eisai Co., Ltd.'s (ESALY) next earnings date is currently unknown.
-
Does Eisai Co., Ltd. pay dividends?
Yes, Eisai Co., Ltd. pays dividends and its trailing 12-month yield is 0.01% with 170% payout ratio.It means that the company is paying a dividend greater than earnings. The last Eisai Co., Ltd. stock dividend of undefined was paid on 6 Sep 2025.
-
How much money does Eisai Co., Ltd. make?
Eisai Co., Ltd. has a market capitalization of 17.63B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.07% to 756.23B US dollars.
-
What is Eisai Co., Ltd.'s stock symbol?
Eisai Co., Ltd. is traded on the OTC under the ticker symbol "ESALY".
-
What is Eisai Co., Ltd.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Eisai Co., Ltd.?
Shares of Eisai Co., Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Eisai Co., Ltd. have?
As Jul 2024, Eisai Co., Ltd. employs 11,092 workers.
-
When Eisai Co., Ltd. went public?
Eisai Co., Ltd. is publicly traded company for more then 29 years since IPO on 1 Dec 1995.
-
What is Eisai Co., Ltd.'s official website?
The official website for Eisai Co., Ltd. is eisai.co.jp.
-
How can i contact Eisai Co., Ltd.?
Eisai Co., Ltd. can be reached via phone at +81 3 3817 3700.
Eisai Co., Ltd. company profile:

Eisai Co., Ltd.
eisai.co.jpOTC
11,092
Drug Manufacturers—Specialty & Generic
Healthcare
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Tokyo, 112-8088
:
ISIN: US2825793092
: